New maintenance drug shows promise in T-Cell lymphoma after transplant
NCT ID NCT01908777
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 25 times
Summary
This study tested whether giving the drug romidepsin after a stem cell transplant can help keep T-cell non-Hodgkin lymphoma from coming back. 47 adults whose lymphoma was in remission received high-dose chemotherapy, a stem cell transplant, then romidepsin as maintenance therapy. The goal was to see how many patients remained cancer-free two years later.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T CELL NON-HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fred Hutchinson Cancer Research Center (Data Collection Only)
Seattle, Washington, 98109, United States
-
Memorial Sloan Kettering Cancer Center
Basking Ridge, New Jersey, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 11065, United States
-
Memorial Sloan Kettering Cancer Center @ Suffolk
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Nassau
Uniondale, New York, 11553, United States
-
Memorial Sloan Kettering Westchester
Harrison, New York, 10604, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
University of Washington (Data Collection Only)
Seattle, Washington, 98109, United States
-
Weill Cornell Medical Center
New York, New York, United States
Conditions
Explore the condition pages connected to this study.